These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22274570)

  • 21. Botulinum toxin type A as an effective prophylactic treatment in primary headache disorders.
    Blumenfeld A
    Headache; 2003 Sep; 43(8):853-60. PubMed ID: 12940806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Daily Headache in Chronic Migraine Is a Predictive Factor of Response in Patients Who Had Completed Three Sessions of OnabotulinumtoxinA.
    Martínez-Pías E; Guerrero ÁL; Sierra Á; Trigo J; García-Azorín D
    Toxins (Basel); 2021 Jun; 13(6):. PubMed ID: 34205832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New Daily Persistent Headache and OnabotulinumtoxinA Therapy.
    Ali A; Kriegler J; Tepper S; Vij B
    Clin Neuropharmacol; 2019; 42(1):1-3. PubMed ID: 30499777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial.
    Diener HC; Dodick DW; Aurora SK; Turkel CC; DeGryse RE; Lipton RB; Silberstein SD; Brin MF;
    Cephalalgia; 2010 Jul; 30(7):804-14. PubMed ID: 20647171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of chronic daily headache with comorbid anxiety and depression using botulinum toxin A: a prospective pilot study.
    Zhang H; Zhang H; Wei Y; Lian Y; Chen Y; Zheng Y
    Int J Neurosci; 2017 Apr; 127(4):285-290. PubMed ID: 27439999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial.
    Mathew NT; Frishberg BM; Gawel M; Dimitrova R; Gibson J; Turkel C;
    Headache; 2005 Apr; 45(4):293-307. PubMed ID: 15836565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Effect of OnabotulinumtoxinA on Aura Frequency and Severity in Patients With Hemiplegic Migraine: Case Series of 11 Patients.
    Chen TY; Garza I; Dodick DW; Robertson CE
    Headache; 2018 Jul; 58(7):973-985. PubMed ID: 29762872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective analysis of the use of OnabotulinumtoxinA (BOTOX) in the treatment of chronic migraine; real-life data in 254 patients from Hull, U.K.
    Khalil M; Zafar HW; Quarshie V; Ahmed F
    J Headache Pain; 2014 Sep; 15(1):54. PubMed ID: 25178393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term benefits of botulinum toxin type A (BOTOX) in chronic daily headache: a five-year long experience.
    Farinelli I; Coloprisco G; De Filippis S; Martelletti P
    J Headache Pain; 2006 Dec; 7(6):407-12. PubMed ID: 17149565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine.
    Lipton RB; Varon SF; Grosberg B; McAllister PJ; Freitag F; Aurora SK; Dodick DW; Silberstein SD; Diener HC; DeGryse RE; Nolan ME; Turkel CC
    Neurology; 2011 Oct; 77(15):1465-72. PubMed ID: 21956721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
    Dodick DW; Mauskop A; Elkind AH; DeGryse R; Brin MF; Silberstein SD;
    Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of onabotulinumtoxinA (BOTOX®) for the preventive treatment of chronic migraine: A meta-analysis on 10 years of real-world data.
    Lanteri-Minet M; Ducros A; Francois C; Olewinska E; Nikodem M; Dupont-Benjamin L
    Cephalalgia; 2022 Dec; 42(14):1543-1564. PubMed ID: 36081276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of response to botulinum toxin type A (BoNTA) in chronic daily headache.
    Mathew NT; Kailasam J; Meadors L
    Headache; 2008 Feb; 48(2):194-200. PubMed ID: 17868356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An open-label prospective study of the real-life use of onabotulinumtoxinA for the treatment of chronic migraine: the REPOSE study.
    Ahmed F; Gaul C; García-Moncó JC; Sommer K; Martelletti P;
    J Headache Pain; 2019 Mar; 20(1):26. PubMed ID: 30845917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Onabotulinumtoxin A (BOTOX®) for ProphylaCTIC Treatment of Pediatric Migraine: A Retrospective Longitudinal Analysis.
    Shah S; Calderon MD; Wu W; Grant J; Rinehart J
    J Child Neurol; 2018 Aug; 33(9):580-586. PubMed ID: 29877131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of headache relief with cosmetic onabotulinumtoxinA injections.
    Goldman ND; Dorton LH; Marcum KK; Gilbert RM; Sandoval LF
    J Cosmet Dermatol; 2014 Sep; 13(3):224-31. PubMed ID: 25196690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dispute settlement understanding on the use of Botox in chronic migraine.
    Martelletti P
    J Headache Pain; 2011 Feb; 12(1):1-2. PubMed ID: 21246242
    [No Abstract]   [Full Text] [Related]  

  • 38. Influence of headache pain intensity and frequency on migraine-related disability in chronic migraine patients treated with OnabotulinumtoxinA.
    Torres-Ferrus M; Gallardo VJ; Alpuente A; Pozo-Rosich P
    J Headache Pain; 2020 Jul; 21(1):88. PubMed ID: 32652924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Botulinum neurotoxin for the treatment of migraine and other primary headache disorders: from bench to bedside.
    Dodick DW
    Headache; 2003; 43 Suppl 1():S25-33. PubMed ID: 12887391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.